Ocugen (OCGN) Other Non-Current Assets (2014 - 2026)
Ocugen (OCGN) reported Other Non-Current Assets of $4.2 million for Q1 2026, up 1261.17% on a YoY basis from $309000.0 in Q1 2025, and up 1231.01% quarter-over-quarter from $316000.0 in Q4 2025.
Ocugen (OCGN) Other Non-Current Assets (2014 - 2026) Analysis & Trends
Ocugen has reported Other Non-Current Assets for 13 years, with the latest figure at $4.2 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets rose 1261.17% year-over-year to $4.2 million; the trailing twelve-month figure through Mar 2026 stood at $4.2 million (up 1261.17% YoY), and the FY2025 full-year result was $316000.0, up 2.93% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $4.2 million, up from $316000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $5.0 million in Q2 2025, with the low at $302000.0 in Q2 2024.
- Historically, Other Non-Current Assets has averaged $2.3 million across 5 years, with a median of $1.6 million in 2022.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets jumped 2791.39% — and 2025, when it rose 2.93%.
- Ocugen's Other Non-Current Assets stood at $4.1 million in 2022, then fell by 3.45% to $3.9 million in 2023, then plunged by 92.22% to $307000.0 in 2024, then gained by 2.93% to $316000.0 in 2025, then jumped by 1231.01% to $4.2 million in 2026.
- The last three Other Non-Current Assets figures came in at $4.2 million (Q1 2026), $316000.0 (Q4 2025), and $314000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - | 4.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.21 Mn |
| Dec 31, 2025 | 316,000.00 |
| Sep 30, 2025 | 314,000.00 |
| Jun 30, 2025 | 4.95 Mn |
| Mar 31, 2025 | 309,000.00 |
| Dec 31, 2024 | 307,000.00 |
| Sep 30, 2024 | 305,000.00 |
| Jun 30, 2024 | 302,000.00 |
| Mar 31, 2023 | 3.95 Mn |
| Dec 31, 2022 | 4.09 Mn |
| Sep 30, 2022 | 4.23 Mn |
| Jun 30, 2022 | 4.37 Mn |
| Mar 31, 2022 | 1.63 Mn |
| Dec 31, 2021 | 151,000.00 |
| Sep 30, 2021 | 151,000.00 |
| Jun 30, 2021 | 151,000.00 |
| Mar 31, 2021 | 151,000.00 |
| Dec 31, 2020 | 714,000.00 |
| Sep 30, 2020 | 151,000.00 |
| Jun 30, 2020 | 151,000.00 |